Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

NASDAQ:ENTA

Overview | Financials
Company Name Enanta Pharmaceuticals, Inc.
Symbol ENTA
Currency USD
Price 13.43
Market Cap 284,439,342
Dividend Yield 0%
52-week-range 8.08 - 24.57
Industry Biotechnology
Sector Healthcare
CEO Dr. Jay R. Luly Ph.D.
Website https://www.enanta.com

An error occurred while fetching data.

About Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories

Related Stocks

Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

ACRS

1.19 USD

Kura Oncology, Inc. logo

Kura Oncology, Inc.

KURA

21.57 USD

Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc.

SANA

7.15 USD

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

26.68 USD

FibroGen, Inc. logo

FibroGen, Inc.

FGEN

1.16 USD

Cutera, Inc. logo

Cutera, Inc.

CUTR

1.79 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

20.7 USD

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

49.5 USD

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

13.08 USD

Financials

Numbers are in millions USD

Numbers are in millions USD